Patient Portal

Close this search box.

Meet The EVO ICL

After all, a video is worth a thousand words…

Upgrade Your Vision

Understand Your Refractive Options

This video helps explain the differences between LASIK, PRK, and EVO ICL

What Is EVO ICL?

Newsom Eye was amongst the first practices in Tampa and Sebring, Florida to implant the groundbreaking EVO ICL. This revolutionary refractive implant, developed by STAAR Surgical, is designed to correct and enhance vision for issues such as nearsightedness and astigmatism, without removing any corneal tissue. This state-of-the-art technology offers long-lasting results, potentially eliminating the need for glasses or contact lenses for clear vision. Unlike permanent laser procedures like LASIK or PRK, the EVO ICL can be removed or replaced if necessary in the future, providing you with peace of mind. Our Florida vision correction team at Newsom Eye will help determine if the EVO is the best option for you.

Play Video about ICL Procedure


Experience The Clarity Of The EVO ICL

At Newsom Eye, we are committed to providing exceptional vision correction solutions in Tampa, Sebring, and the surrounding Florida area. We pride ourselves on being more than just an ordinary LASIK clinic. Our team offers a wide range of vision correction alternatives and assists patients in selecting the most suitable option for their needs. We are delighted to be one of the first practices in Florida to provide the EVO ICL, a groundbreaking treatment that can potentially elevate your vision beyond glasses, beyond contact lenses, and possibly, even beyond 20/20.

How Does The EVO ICL Work?

Play Video about EVO ICL Work

Treat Nearsightedness With The EVO ICL Vision Correction Procedure!

Play Video about Nearsightedness

What Is The Difference Between EVO ICL and LASIK?

Play Video about EVO ICL

EVO ICL Receives FDA Approval!

Play Video about Evo ICL FDA Approval

Who Is A Good Candidate For The EVO ICL?

The EVO ICL is an excellent vision correction option for those 21-45, who wear glasses or contacts for nearsightedness (myopia) with or without astigmatism. At Newsom Eye, many patients who suffer from a high degree of nearsightedness or astigmatism are often better candidates for the EVO ICL over LASIK or PRK. ICL lens candidates should meet the following criteria to qualify for the surgical procedure:

  • Be between 21 and 45 years old
  • Correction or reduction of myopia with or without astigmatism with spherical equivalent ranging from -3.0 D to -20,0 D and cylinder from 1.0 D to 4.0 D at the spectacle plane
  • With an anterior chamber depth (ACD) equal to or greater than 3.00 mm, as measured from the corneal endothelium to the anterior lens capsule
  • Stable refractive history (within 0.5 D one year prior to implantation)
  • Have not changed your prescription eyewear by more than 0.5D in a year

If you fall into these categories, the EVO ICL might be good for you. Age is an important factor as older generations — people aged 45 and above — may develop presbyopia or early cataracts, which can interfere with your vision clarity. These patients are often better candidates for Refractive Lens Exchange.

How Is The EVO ICL Procedure Performed?

ICL surgery typically takes 30 minutes or less. Dr. Newsom then creates tiny micro incisions near the cornea to allow positioning of the lens between the iris and natural lens. Then, he will carefully implant the lens through these micro-incisions, and the implant will unfold on its own.

Patients are given eye drops to use at home for post-operative care once the surgery is complete.

With most EVO ICL procedures, patients can typically see incredibly well immediately following the procedure, with vision improving over the next several days!

EVO ICL Compared To Other Vision Correction Procedures

EVO Comparison Chart

The Complete Guide To EVO ICL

This free guide is meant to help people who need vision correction make decisions. You will learn about:

  • How EVO works
  • Benefits of EVO ICL
  • The procedure

Click the link BELOW to download brochure


EVO is an evolution in vision correction? a clinically-proven implantable lens that corrects common vision problems such as nearsightedness and nearsightedness with astigmatism, which is the need fordistance vision correction. EVO can be the solution for people who want to get rid of their glasses or contact lenses.

The EVO ICL lens is made from Collamer, a collagen co-polymer that is proprietary to STAAR Surgical. Collamer is biocompatible, stable, and flexible, thus making it an ideal lens material for the eye. It has a long history of successful in-eye use.

EVO is a globally trusted and tested procedure. According to a STAAR patient survey, 99.4% of patients would have the EVO procedure again.6 Over 1,000,000 EVO ICL lenses have been implanted around the world. And now the EVO ICL has been confirmed by the U.S. FDA to be a safe and effective treatment of moderate to high nearsightedness with or without astigmatism for U.S. patients.

The most recent U.S. clinical trial of the EVO ICL reviewed by FDA is summarized in the EVO/EVO+ ICL Directions for Use (DFU) and the FDA’s Summary of Safety and Effectiveness Data (SSED) issued with the PMA Approval notice. Hundreds of peer-reviewed papers from dozens of countries report the safety and efficacy of EVO. Select papers are listed below including a comprehensive literature review of peer-reviewed papers bringing together the safety and effectiveness data from 67 preclinical studies and clinical reports. In these studies, 4,196 eyes reported safety data and 1,905 eyes reported effectiveness data.

  • Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clinical Ophthalmology 2018:12: 2427-2438.
  • Martinez-Plazs E, Lopez-Miguel A, Lopez-De La Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226: 117-125.
  • Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017;11:1253-1263

Both EVO and LASIK are effective vision correction options. EVO offers a great way to break free from glasses and contact lenses while not having to remove corneal tissue as in laser vision correction procedures. The EVO lens is additive; meaning, it is implanted in the eye and doesn’t remove corneal tissue. The EVO lens works in harmony with the natural eye while delivering sharp, clear vision, excellent night vision, UV protection, and does not cause dry eye syndrome. If desired, the EVO lens is removable by a doctor providing patients added peace of mind. Your Newsom Eye doctor will let you know if LASIK or EVO is best suited for your unique vision.

Most likely not as the safety and effectiveness of EVO for the correction of moderate to high myopia with and without astigmatism has not been established in patients with a previous history of ocular surgery.

Both are FDA-approved as safe and effective. EVO can be a better option for patients than contacts for a variety of reasons including efficiency, cost, and convenience. In terms of costs, on average, contact lenses cost $12,000 over a lifetime. (Your personal cost will vary). Because EVO is a long-term solution, your procedure costs are generally fixed to a one-time fee. When you compare with the long-term costs of contact lenses, EVO typically pays for itself. Finally, EVO lenses can free contacts and glasses wearers from the daily inconvenience and maintenance associated with contacts and glasses.

To schedule an ICL consultation, please call 813-908-2020 and select option 2.

Request An

You deserve

To request a consultation with Newsom Eye, please click link below.